Congratulations go to the CRF EXALT Study team, lead by Bijay Vaidya (phase 1 study in Type 1 Diabetes) who have recruited to target and who’s last patient has now closed the study to all recruitment across Europe.  It ended with an emense team effort.  Well done everyone.